Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Other Non-Current Assets: 2016-2025

Historic Other Non-Current Assets for Collegium Pharmaceutical (COLL) over the last 10 years, with Sep 2025 value amounting to $2.3 million.

  • Collegium Pharmaceutical's Other Non-Current Assets fell 43.95% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year decrease of 43.95%. This contributed to the annual value of $8.4 million for FY2024, which is 699.24% up from last year.
  • Collegium Pharmaceutical's Other Non-Current Assets amounted to $2.3 million in Q3 2025, which was down 39.19% from $3.8 million recorded in Q2 2025.
  • In the past 5 years, Collegium Pharmaceutical's Other Non-Current Assets ranged from a high of $8.4 million in Q4 2024 and a low of $1.0 million during Q2 2023.
  • In the last 3 years, Collegium Pharmaceutical's Other Non-Current Assets had a median value of $2.3 million in 2025 and averaged $2.9 million.
  • In the last 5 years, Collegium Pharmaceutical's Other Non-Current Assets crashed by 58.89% in 2023 and then spiked by 699.24% in 2024.
  • Quarterly analysis of 5 years shows Collegium Pharmaceutical's Other Non-Current Assets stood at $2.5 million in 2021, then remained steady at $2.5 million in 2022, then slumped by 58.89% to $1.0 million in 2023, then spiked by 699.24% to $8.4 million in 2024, then plummeted by 43.95% to $2.3 million in 2025.
  • Its last three reported values are $2.3 million in Q3 2025, $3.8 million for Q2 2025, and $5.0 million during Q1 2025.